Tetrahydrozoline Hydrochloride is an imidazoline-derived alpha-adrenergic agonist used as a topical decongestant. It works by stimulating alpha-adrenergic receptors in the vascular smooth muscle, leading to vasoconstriction and a reduction in redness, swelling, and congestion. It is commonly found in over-the-counter (OTC) eye drops and nasal sprays.
Indications include:
∙ Relief of ocular redness due to minor eye irritations (e.g., dust, smoke, allergies)
∙ Temporary relief of nasal congestion (in some formulations)
∙ Used topically only; not intended for systemic use
Parent: Tetrahydrozoline Hydrochloride
Impurities in tetrahydrozoline hydrochloride arise from multi-step chemical synthesis involving imidazoline formation and from degradation during storage, particularly under light, heat, or pH stress. As it is used ophthalmically or nasally, impurity levels must comply with ICH Q3A/B, USP/EP, and FDA OTC monograph standards.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
It is used to relieve eye redness and nasal congestion by causing vasoconstriction in small blood vessels.
It activates alpha-adrenergic receptors, leading to constriction of dilated blood vessels, which reduces redness and swelling in the eyes or nasal passages.
No. Prolonged use can lead to rebound congestion or redness. It should be used only for short durations (typically ≤3–5 days) unless directed by a healthcare professional.
It is light-sensitive and prone to oxidative degradation, especially in aqueous solutions. Products should be stored in light-protective containers at controlled room temperature.
